What Otolaryngologists Need to Know about Biologics and Allergic Rhinitis
Researchers and otolaryngologists are considering the use of biologic agents to manage allergic rhinitis (AR), a common, non-life-threatening condition.
Researchers and otolaryngologists are considering the use of biologic agents to manage allergic rhinitis (AR), a common, non-life-threatening condition.
We explore the potential personal, professional, and legal consequences of physicians taking a stand.
As with tobacco years ago, framing gun violence as a health issue affecting both individuals and the public can be a hard sell.
Given the unsettled nature of the iodinated contrast supply chain, otolaryngologists should be considering when it may be appropriate to switch to alternative scanning modalities.
Otolaryngologist leaders offer their analyses of today’s unique business climate and and give advice on how otolaryngologists can address challenges and maximize opportunities.
When the way we come together with our patients and treat them is compromised, it strains our ability to perform our jobs.
The negotiation process is a key determinant of success for a newly hired physician employee, and it doesn’t have to be stressful.
Compared to traditional open surgery, endoscopic procedures are associated with less patient morbidity and shorter postoperative recovery.
What is the status of existing reporting guidelines for machine learning (ML) in biomedical publications and present recommendations for their use in otolaryngology journal reports? BOTTOM LINE There is limited […]
What do variables in the National Cancer Database (NCDB) suggest about treatment decisions between surgery and radiation for early stage glottic carcinoma (EGC)? BOTTOM LINE Most patients in the NCDB […]
Age and smoking, but not body mass index, are associated with laryngopharyngeal reflux (LPR).
The Questionnaire of Olfactory Disorders (QOD) might help predict symptoms of depression in olfactory dysfunction (OD) patients.
Care delays related to evaluations by multiple providers and misdiagnosis prolong the time to diagnosis in patients with oropharyngeal squamous cell carcinoma that is not associated with, or negative for, human papillomavirus.
The study looks at the status of the otolaryngology field today in terms of diversity in leadership.
In the era of effective adjuvant systemic therapies, the use of ICI alone in the adjuvant setting may be insufficient to effectively reduce regional failure.
Surgical incision using electrocautery can be quicker, with less blood loss and better postoperative pain scores.
There is enough evidence to support posterior nasal nerves (PNN) as an effective treatment for allergic rhinitis symptoms, particularly nasal congestion and rhinorrhea.